厂商无关深度学习模型与厂商特定深度学习重建算法在CT中的剂量降低潜力比较:体模研究
该体模研究比较了厂商无关深度学习模型(ClariCT.AI)与厂商特定深度学习重建算法(TrueFidelity™)的剂量降低潜力(DRP)。在六种辐射剂量水平下,DRP分别为:DLM 86%(81-88%)、DLR-low 60%(46-67%)、DLR-medium 76%(60-81%)、DLR-high 87%(78-92%)。结论认为,厂商无关DLM的DRP与高强度DLR相当,且优于中、低强度DLR。
要点
- 厂商无关DLM的剂量降低潜力与高强度厂商特定DLR相当。
- DLM的DRP优于中、低强度DLR。
- 在不同辐射剂量水平下,DLM相比FBP具有更高的检测指数。
核心结论
- 厂商无关DLM的剂量降低潜力与高强度厂商特定DLR相当,且优于中、低强度DLR。
研究设计与样本
- 体模研究,使用多尺寸图像质量体模(Mercury v4.0),在六种辐射剂量水平(0.48/0.97/1.93/3.87/7.74/15.47 mGy)下采集CT图像。
- 图像重建采用滤波反投影(FBP)和三种强度水平的DLR(低/中/高),FBP图像经DLM去噪。
- 在三种目标尺寸(10/5/1 mm)、五种入口(与背景的CT值差:-895/50/90/335/1000 HU)、五种体模直径(36/31/26/21/16 cm)和六种辐射剂量水平的组合下,获取检测指数(d')。
- 剂量降低潜力(DRP)定义为使用DLM或DLR时,达到与全剂量FBP等效的d'时所降低的剂量。
诊断标准与关键数值
- DLM、DLR-low、DLR-medium、DLR-high的DRP分别为86%(81-88%)、60%(46-67%)、76%(60-81%)、87%(78-92%)。
- 对于10 mm目标,DLM的DRP(87%)高于所有DLR算法(58-86%)。
- 对于更小目标(5 mm/1 mm),DLR-high的DRP(89/88%)大于DLM(87/84%)。
临床应用与阅片要点
- 厂商无关DLM可在不依赖特定厂商的情况下提供与高强度DLR相当的剂量降低潜力,适用于多厂商CT设备的剂量优化。
- 对于小目标(5 mm/1 mm)的检测任务,高强度DLR可能提供更高的剂量降低潜力,需根据临床任务选择重建算法。
局限性
- 本研究为体模研究,结果需在临床环境中进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To compare the dose reduction potential (DRP) of a vendor-agnostic deep learning model (DLM, ClariCT.AI) with that of a vendor-specific deep learning-based image reconstruction algorithm (DLR, TrueFidelity™).
METHODS: Computed tomography (CT) images of a multi-sized image quality phantom (Mercury v4.0) were acquired under six radiation dose levels (0.48/0.97/1.93/3.87/7.74/15.47 mGy) and were reconstructed using filtered back projection (FBP) and three strength levels of the DLR (low/medium/high). The FBP images were denoised using the DLM. For all DLM and DLR images, the detectability index (d') (a task-based detection performance metric) was obtained, under various combinations of three target sizes (10/5/1 mm), five inlets (CT value difference with the background; -895/50/90/335/1000 HU), five phantom diameters (36/31/26/21/16 cm), and six radiation dose levels. Dose reduction potential (DRP) measures the dose reduction made by using DLM or DLR, while yielding d' equivalent to that of FBP at full dose.
RESULTS: The DRPs of the DLM, DLR-low, DLR-medium, and DLR-high were 86% (81-88%), 60% (46-67%), 76% (60-81%), and 87% (78-92%), respectively. For 10-mm targets, the DRP of the DLM (87%) was higher than that of all DLR algorithms (58-86%). However, for smaller targets (5 mm/1 mm), the DRPs of the DLR-high (89/88%) were greater than those of the DLM (87/84%).
CONCLUSION: The dose reduction potential of the vendor-agnostic DLM was shown to be comparable to that of the vendor-specific DLR at high strength and superior to those of the DLRs at medium and low strengths.
KEY POINTS: • DRP of the vendor-agnostic model was comparable to that of high-strength vendor-specific model and superior to those of medium- and low-strength models. • Under various radiation dose levels, the deep learning model shows higher detectability indexes compared to FBP.
引用
- Choi H, Chang W, Kim JH, et al. Dose reduction potential of vendor-agnostic deep learning model in comparison with deep learning-based image reconstruction algorithm on CT: a phantom study. Eur Radiol. 2021. PMID: 34390372. doi:10.1007/s00330-021-08199-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。